Observational Studies Versus Randomized Controlled Trials: Avenues to Causal Inference in Nephrology

被引:53
作者
Kovesdy, Csaba P. [1 ]
Kalantar-Zadeh, Kamyar
机构
[1] Salem VA Med Ctr, Div Nephrol, Salem, VA 24153 USA
关键词
Observational studies; Randomized controlled trials; Causal inference; VITAMIN-D COMPOUNDS; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; BLOOD-PRESSURE; SURVIVAL; MORTALITY; ASSOCIATION; HEMOGLOBIN; RISK; PARICALCITOL;
D O I
10.1053/j.ackd.2011.09.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A common frustration for practicing Nephrologists is the adage that the lack of randomized controlled trials (RCTs) does not allow us to establish causality, but merely associations. The field of nephrology, like many other disciplines, has been suffering from a lack of RCTs. The view that without RCTs, there is no reliable evidence has hampered our ability to ascertain the best course of action for our patients. However, many clinically important questions in medicine and public health, such as the association of smoking and lung cancer, are not amenable to RCTs owing to ethical or other considerations. Whereas RCTs unquestionably hold many advantages over observational studies, it should be recognized that they also have many flaws that render them fallible under certain circumstances. We provide a description of the various pros and cons of RCTs and of observational studies using examples from the nephrology literature, and argue that it is simplistic to rank them solely based on preconceived notions about the superiority of one over the other. We also discuss methods whereby observational studies can become acceptable tools for causal inferences. Such approaches are especially important in a field like nephrology where there are myriads of potential interventions based on complex pathophysiologic states, but where properly designed and conducted RCTs for all of these will probably never materialize. Published by the National Kidney Foundation, Inc.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 38 条
  • [1] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [2] Clinical pharmacology in the Middle Ages: Principles that presage the 21st century
    Brater, DC
    Daly, WJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (05) : 447 - 450
  • [3] A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis
    Cooper, Bruce A.
    Branley, Pauline
    Bulfone, Liliana
    Collins, John F.
    Craig, Jonathan C.
    Fraenkel, Margaret B.
    Harris, Anthony
    Johnson, David W.
    Kesselhut, Joan
    Li, Jing Jing
    Luxton, Grant
    Pilmore, Andrew
    Tiller, David J.
    Harris, David C.
    Pollock, Carol A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) : 609 - 619
  • [4] Coyne DW, 2008, ANN INTERN MED, V148, P969, DOI 10.7326/0003-4819-148-12-200806170-00013
  • [5] Normalization of hemoglobin level in patients with chronic kidney disease and anemia
    Drueke, Tilman B.
    Locatelli, Francesco
    Clyne, Naomi
    Eckardt, Kai-Uwe
    Macdougall, Iain C.
    Tsakiris, Dimitrios
    Burger, Hans-Ulrich
    Scherhag, Armin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) : 2071 - 2084
  • [6] Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
    Fellstroem, Bengt C.
    Jardine, Alan G.
    Schmieder, Roland E.
    Holdaas, Hallvard
    Bannister, Kym
    Beutler, Jaap
    Chae, Dong-Wan
    Chevaile, Alejandro
    Cobbe, Stuart M.
    Groenhagen-Riska, Carola
    De Lima, Jose J.
    Lins, Robert
    Mayer, Gert
    McMahon, Alan W.
    Parving, Hans-Henrik
    Remuzzi, Giuseppe
    Samuelsson, Ola
    Sonkodi, Sandor
    Sueleymanlar, Gultekin
    Tsakiris, Dimitrios
    Tesar, Vladimir
    Todorov, Vasil
    Wiecek, Andrzej
    Wuethrich, Rudolf P.
    Gottlow, Mattis
    Johnsson, Eva
    Zannad, Faiez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14) : 1395 - 1407
  • [7] Glymour MM., 2008, Modern epidemiology, V3rd ed., P183
  • [8] ENVIRONMENT AND DISEASE - ASSOCIATION OR CAUSATION
    HILL, AB
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1965, 58 (05): : 295 - +
  • [9] Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease - A randomized controlled trial
    Jamison, Rex L.
    Hartigan, Pamela
    Kaufman, James S.
    Goldfarb, David S.
    Warren, Stuart R.
    Guarino, Peter D.
    Gaziano, J. Michael
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1163 - 1170
  • [10] Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
    Kalantar-Zadeh, K.
    Kuwae, N.
    Regidor, D. L.
    Kovesdy, C. P.
    Kilpatrick, R. D.
    Shinaberger, C. S.
    McAllister, C. J.
    Budoff, M. J.
    Salusky, I. B.
    Kopple, J. D.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (04) : 771 - 780